Viridian Therapeutics, Inc.\DE Growth Metrics (2013-2026) | VRDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.21M		15.42M	-1.07M	-0.99M	0.43M	-3.31M	-6.20M	-7.08M	-6.87M	-5.25M	-0.37M	-1.79M	-2.59M	-2.22M	-5.27M	-4.21M	9.70M	2.85M	4.80M
EBITDA Margin Growth (3y) (Quarter)	-0.12M	-0.58M	-1.14M	-0.88M	-1.13M	-0.16M		-7.30M	-7.85M		6.85M	-7.64M	-9.86M	-9.03M	-10.79M	-11.84M	-13.08M	0.24M	-4.63M	-0.84M
EBITDA Margin Growth (5y) (Quarter)	-0.13M	-0.64M	-1.24M	-1.05M	-1.05M	-0.21M	-4.62M	-7.39M	-8.19M	-7.02M	-9.71M	-7.45M	-10.00M	-9.62M		-12.94M	-13.86M		7.48M	-8.11M
EBITDA Margin (QoQ) (Quarter)	-0.04M	-0.51M	-0.68M	0.16M	0.04M	0.91M	-4.42M	-2.72M	-0.84M	1.12M	-2.81M	2.16M	-2.26M	0.32M	-2.44M	-0.89M	-1.20M	14.23M	-9.29M	1.06M
EBIT Margin Growth (1y) (Quarter)	0.21M		15.42M	-1.07M	-0.99M	0.43M	-3.31M	-6.20M	-7.08M	-6.87M	-5.25M	-0.37M	-1.79M	-2.59M	-2.22M	-5.27M	-4.21M	9.70M	2.85M	4.80M
EBIT Margin Growth (3y) (Quarter)	-0.12M	-0.58M	-1.14M	-0.88M	-1.13M	-0.16M		-7.30M	-7.85M		6.85M	-7.64M	-9.86M	-9.03M	-10.79M	-11.84M	-13.08M	0.24M	-4.63M	-0.84M
EBIT Margin Growth (5y) (Quarter)	-0.13M	-0.64M	-1.24M	-1.05M	-1.05M	-0.21M	-4.62M	-7.39M	-8.19M	-7.02M	-9.71M	-7.45M	-10.00M	-9.62M		-12.94M	-13.86M		7.48M	-8.11M
EBIT Margin (QoQ) (Quarter)	-0.04M	-0.51M	-0.68M	0.16M	0.04M	0.91M	-4.42M	-2.72M	-0.84M	1.12M	-2.81M	2.16M	-2.26M	0.32M	-2.44M	-0.89M	-1.20M	14.23M	-9.29M	1.06M
EBT Margin Growth (1y) (Quarter)	0.25M		15.44M	-1.06M	-0.99M	0.43M	-2.98M	-5.77M	-6.49M	-6.38M	-7.35M	-1.05M	-2.49M	-4.02M	0.71M	-5.07M	-4.76M	10.63M	3.48M	5.15M
EBT Margin Growth (3y) (Quarter)	-0.12M	-0.58M	-1.14M	-0.87M	-1.13M	-0.15M		-6.85M	-7.23M		5.11M	-7.88M	-9.97M	-9.96M	-9.62M	-11.89M	-13.74M	0.24M	-3.16M	-0.97M
EBT Margin Growth (5y) (Quarter)	-0.13M	-0.63M	-1.25M	-1.03M	-1.05M	-0.20M	-4.29M	-6.95M	-7.61M	-6.52M	-11.47M	-7.69M	-10.11M	-10.55M		-12.97M	-14.47M		9.30M	-7.80M
EBT Margin (QoQ) (Quarter)	-0.03M	-0.51M	-0.69M	0.17M	0.04M	0.91M	-4.10M	-2.62M	-0.69M	1.03M	-5.07M	3.68M	-2.12M	-0.50M	-0.35M	-2.09M	-1.81M	14.88M	-7.50M	-0.43M
Enterprise Value Growth (1y) (Quarter)	-257.40%	-610.83%	-54.31%	-49.81%	-47.49%	-101.73%	-115.55%	-113.11%	-107.37%	27.43%	-12.44%	-64.02%	-70.92%	-140.65%	-50.32%	-3.82%	1.40%	34.83%	-21.89%	-19.72%
Enterprise Value Growth (3y) (Quarter)	-12.75%	-44.73%	-46.63%	-50.91%	-54.22%	-133.60%	-151.01%	-117.97%	-121.93%	-118.32%	-55.22%	-73.65%	-73.55%	-52.16%	-53.87%	-53.67%	-51.75%	-4.41%	-27.24%	-26.80%
Enterprise Value Growth (5y) (Quarter)	-67.15%	-54.11%	-54.88%	-30.51%	-28.32%	-58.73%	-55.01%	-36.78%	-34.39%	-34.72%	-50.18%	-64.41%	-67.03%	-86.00%	-92.93%	-77.53%	-79.09%	-74.80%	-46.95%	-45.45%
Enterprise Value (QoQ) (Quarter)	6.66%	-95.62%	7.88%	10.93%	8.11%	-167.56%	1.57%	11.94%	10.58%	6.37%	-52.51%	-28.45%	6.82%	-31.83%	4.73%	11.28%	11.51%	12.86%	-78.17%	12.86%
FCF Margin Growth (1y) (Quarter)	0.27M		0.99M	-0.90M	-0.56M	0.40M	-2.46M	-5.35M	-5.63M	-5.29M	-2.06M	0.05M	-0.09M	-2.44M	-4.92M	-6.60M	-3.64M	7.89M	8.38M	4.39M
FCF Margin Growth (3y) (Quarter)	-0.11M	-0.51M	-0.59M	-0.66M	-0.67M	-0.10M		-6.23M	-5.92M		-3.54M	-6.20M	-6.28M	-7.33M	-9.44M	-11.90M	-9.36M	0.17M	1.41M	-2.15M
FCF Margin Growth (5y) (Quarter)	-0.09M	-0.55M	-0.70M	-0.80M	-0.60M	-0.14M	-3.16M	-6.32M	-6.30M	-5.40M	-5.11M	-5.96M	-6.39M	-7.83M		-12.78M	-9.65M		-0.07M	-8.41M
FCF Margin (QoQ) (Quarter)	-0.06M	-0.44M	-0.18M	-0.22M	0.28M	0.52M	-3.05M	-3.11M	0.01M	0.86M	0.19M	-1.00M	-0.13M	-1.50M	-2.29M	-2.68M	2.83M	10.04M	-1.81M	-6.67M
FCF Payout Ratio (QoQ) (Quarter)
Gross Margin Growth (1y) (Quarter)
Gross Margin Growth (3y) (Quarter)
Gross Margin (QoQ) (Quarter)
Interest Coverage Ratio Growth (1y) (Quarter)			83.63%				1,449.77%		-141.56%	42.67%	-109.10%	85.82%	66.14%	93.70%	-249.65%	-232.19%	81.30%	-1,228.72%	94.01%	80.34%
Interest Coverage Ratio Growth (3y) (Quarter)			-22.14%		-48.81%	-45.87%		-216.53%	-222.73%	-99.08%	41.40%	-3.54%			-62.58%		46.52%	21.71%	-26.39%	54.76%
Interest Coverage Ratio Growth (5y) (Quarter)			-32.70%		-52.04%	-47.60%	153.73%	-87.32%	-62.01%	-15.68%	-17.50%	-0.31%	-21.94%	35.45%		-71.73%	-16.30%	-45.87%	46.93%	6.23%
Interest Coverage Ratio (QoQ) (Quarter)						-0.75%	1,417.87%	-118.46%	1.46%	76.09%	-109.31%	71.25%	-135.36%	95.55%	-11,518.83%	72.68%	86.75%	-216.08%	47.66%	10.28%
Net Margin Growth (1y) (Quarter)	0.22M		15.45M	-1.06M	-0.99M	0.43M	-2.99M	-5.77M	-6.49M	-6.38M	-7.35M	-1.05M	-2.49M	-4.02M	0.71M	-5.07M	-4.76M	10.63M	3.48M	5.15M
Net Margin Growth (3y) (Quarter)	-0.12M	-0.58M	-1.14M	-0.88M	-1.13M	-0.15M	-4.23M	-6.86M	-7.26M		5.11M	-7.89M	-9.97M	-9.96M	-9.63M	-11.89M	-13.74M	0.24M	-3.16M	-0.97M
Net Margin Growth (5y) (Quarter)	-0.13M	-0.63M	-1.24M	-1.04M	-1.05M	-0.21M	-4.29M	-6.95M	-7.61M	-6.52M	-11.47M	-7.70M	-10.11M	-10.55M	-10.87M	-12.98M	-14.51M		9.30M	-7.80M
Net Margin (QoQ) (Quarter)	-0.04M	-0.51M	-0.68M	0.16M	0.04M	0.91M	-4.10M	-2.62M	-0.69M	1.03M	-5.07M	3.68M	-2.12M	-0.50M	-0.35M	-2.09M	-1.81M	14.88M	-7.50M	-0.43M
Operating Margin Growth (1y) (Quarter)	0.21M		15.42M	-1.07M	-0.99M	0.43M	-3.31M	-6.20M	-7.08M	-6.87M	-5.25M	-0.37M	-1.79M	-2.59M	-2.22M	-5.27M	-4.21M	9.70M	2.85M	4.80M
Operating Margin Growth (3y) (Quarter)	-0.12M	-0.58M	-1.14M	-0.88M	-1.13M	-0.16M		-7.30M	-7.85M		6.85M	-7.64M	-9.86M	-9.03M	-10.79M	-11.84M	-13.08M	0.24M	-4.63M	-0.84M
Operating Margin Growth (5y) (Quarter)	-0.13M	-0.64M	-1.24M	-1.05M	-1.05M	-0.21M	-4.62M	-7.39M	-8.19M	-7.02M	-9.71M	-7.45M	-10.00M	-9.62M		-12.94M	-13.86M		7.48M	-8.11M
Operating Margin (QoQ) (Quarter)	-0.04M	-0.51M	-0.68M	0.16M	0.04M	0.91M	-4.42M	-2.72M	-0.84M	1.12M	-2.81M	2.16M	-2.26M	0.32M	-2.44M	-0.89M	-1.20M	14.23M	-9.29M	1.06M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	1.00	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	-1.00	0.00M	0.00M	0.00M	0.00M	1.00	2.00	1.00	1.00	0.00M	1.00	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)	0.00M	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	1.00	2.00	1.00	1.00	0.00M	1.00	1.00
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	690.00	120.00	175.00	-0.00M	-0.00M	292.00	0.00M	0.00M	0.00M	-593.00	-0.00M	-0.00M	-0.00M	178.00
Return on Capital Employed Growth (3y) (Quarter)	-0.01M	-0.01M	0.00M	0.00M	0.01M	0.02M		0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.00M	-206.00	-181.00	-168.00	-0.00M	-0.00M	-123.00
Return on Capital Employed Growth (5y) (Quarter)	0.01M	0.02M	0.01M	0.00M	-0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	0.00M	0.01M	0.02M		0.02M	0.02M	0.01M	0.01M	0.01M
Return on Capital Employed (QoQ) (Quarter)	-0.00M	0.00M	0.01M	-855.00	-0.00M	0.00M	763.00	-0.00M	-0.00M	-0.00M	679.00	0.00M	62.00	-50.00	224.00	-829.00	-0.00M	328.00	759.00	576.00
Return on Sales Growth (1y) (Quarter)	25.00	-56.00	0.00M	-106.00	-99.00	43.00	-298.00	-577.00	-649.00	-638.00	-735.00	-105.00	-249.00	-402.00	71.00	-507.00	-476.00	0.00M	348.00	515.00
Return on Sales Growth (3y) (Quarter)	-12.00	-58.00	-114.00	-87.00	-113.00	-15.00	-429.00	-685.00	-723.00	-650.00	511.00	-788.00	-997.00	-996.00	-962.00	-0.00M	-0.00M	24.00	-316.00	-97.00
Return on Sales Growth (5y) (Quarter)	-13.00	-63.00	-125.00	-103.00	-105.00	-20.00	-429.00	-695.00	-761.00	-652.00	-0.00M	-769.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	11.00	930.00	-780.00
Return on Sales (QoQ) (Quarter)	-3.00	-51.00	-69.00	17.00	4.00	91.00	-410.00	-262.00	-69.00	103.00	-507.00	368.00	-212.00	-50.00	-35.00	-209.00	-181.00	0.00M	-750.00	-43.00

Research Tools

Developers

Viridian Therapeutics, Inc.\DE Growth Metrics (2013-2026) | VRDN

Research Tools

Developers

Viridian Therapeutics, Inc.\DE Growth Metrics (2013-2026) | VRDN

Create an account

Sign In

Reset Password